[1]
J. Rico-Fontalvo, C. Morales-Portillo, and J. . Bohórquez-Rivero, “In response to: Gliflozins in the management of cardiovascular disease”, Rev. Colomb. Nefrol., vol. 10, no. 2, Feb. 2023.